State Street’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$774K Sell
818,621
-1,788,953
-69% -$1.69M ﹤0.01% 3540
2025
Q1
$1.2M Sell
2,607,574
-110,674
-4% -$51K ﹤0.01% 3390
2024
Q4
$2.01M Buy
2,718,248
+247,033
+10% +$182K ﹤0.01% 3319
2024
Q3
$3.88M Buy
2,471,215
+157,738
+7% +$248K ﹤0.01% 3079
2024
Q2
$3.89M Buy
2,313,477
+325,967
+16% +$548K ﹤0.01% 3040
2024
Q1
$4.77M Buy
1,987,510
+95,191
+5% +$228K ﹤0.01% 2943
2023
Q4
$2.9M Buy
1,892,319
+16,180
+0.9% +$24.8K ﹤0.01% 3180
2023
Q3
$2.04M Buy
1,876,139
+146,027
+8% +$159K ﹤0.01% 3323
2023
Q2
$3.96M Buy
1,730,112
+166,014
+11% +$380K ﹤0.01% 3109
2023
Q1
$3.8M Buy
1,564,098
+47,623
+3% +$116K ﹤0.01% 3096
2022
Q4
$2.9M Buy
1,516,475
+52,906
+4% +$101K ﹤0.01% 3262
2022
Q3
$3.51M Buy
1,463,569
+111,568
+8% +$268K ﹤0.01% 3230
2022
Q2
$2.52M Buy
1,352,001
+27,616
+2% +$51.4K ﹤0.01% 3403
2022
Q1
$2.77M Buy
1,324,385
+109,367
+9% +$229K ﹤0.01% 3445
2021
Q4
$4.79M Buy
1,215,018
+113,265
+10% +$446K ﹤0.01% 3260
2021
Q3
$5.3M Buy
1,101,753
+64,106
+6% +$308K ﹤0.01% 3204
2021
Q2
$4.76M Buy
1,037,647
+287,262
+38% +$1.32M ﹤0.01% 3271
2021
Q1
$4.41M Buy
750,385
+21,791
+3% +$128K ﹤0.01% 3101
2020
Q4
$2.49M Sell
728,594
-21,266
-3% -$72.7K ﹤0.01% 3273
2020
Q3
$1.08M Buy
749,860
+3,922
+0.5% +$5.65K ﹤0.01% 3414
2020
Q2
$1.49M Sell
745,938
-80,879
-10% -$161K ﹤0.01% 3295
2020
Q1
$1.61M Sell
826,817
-69,353
-8% -$135K ﹤0.01% 3142
2019
Q4
$3.72M Sell
896,170
-56,436
-6% -$234K ﹤0.01% 2986
2019
Q3
$2.87M Buy
952,606
+13,654
+1% +$41.1K ﹤0.01% 3082
2019
Q2
$5.91M Buy
938,952
+7,255
+0.8% +$45.6K ﹤0.01% 2741
2019
Q1
$5.18M Sell
931,697
-914,801
-50% -$5.09M ﹤0.01% 2735
2018
Q4
$12.3M Sell
1,846,498
-683,546
-27% -$4.54M ﹤0.01% 2319
2018
Q3
$27M Buy
2,530,044
+529,499
+26% +$5.65M ﹤0.01% 1969
2018
Q2
$24M Sell
2,000,545
-670,584
-25% -$8.05M ﹤0.01% 2004
2018
Q1
$22.9M Buy
2,671,129
+333,095
+14% +$2.85M ﹤0.01% 1963
2017
Q4
$23.1M Buy
2,338,034
+243,100
+12% +$2.4M ﹤0.01% 1951
2017
Q3
$25.7M Buy
2,094,934
+127,679
+6% +$1.57M ﹤0.01% 1842
2017
Q2
$32.4M Buy
1,967,255
+326,088
+20% +$5.36M ﹤0.01% 1651
2017
Q1
$23.5M Buy
1,641,167
+49,802
+3% +$714K ﹤0.01% 1814
2016
Q4
$22M Buy
1,591,365
+233,371
+17% +$3.23M ﹤0.01% 1827
2016
Q3
$24.5M Buy
1,357,994
+75,380
+6% +$1.36M ﹤0.01% 1646
2016
Q2
$18.4M Buy
1,282,614
+73,235
+6% +$1.05M ﹤0.01% 1813
2016
Q1
$14.5M Sell
1,209,379
-190,394
-14% -$2.27M ﹤0.01% 1941
2015
Q4
$18.6M Sell
1,399,773
-1,079,782
-44% -$14.4M ﹤0.01% 1767
2015
Q3
$26.6M Buy
2,479,555
+1,920,172
+343% +$20.6M ﹤0.01% 1555
2015
Q2
$4.5M Buy
559,383
+16,175
+3% +$130K ﹤0.01% 2673
2015
Q1
$3.59M Buy
543,208
+7,724
+1% +$51K ﹤0.01% 2751
2014
Q4
$3.41M Buy
535,484
+17,439
+3% +$111K ﹤0.01% 2768
2014
Q3
$5.11M Buy
518,045
+5,113
+1% +$50.5K ﹤0.01% 2538
2014
Q2
$5.78M Sell
512,932
-574,844
-53% -$6.48M ﹤0.01% 2514
2014
Q1
$13.2M Buy
1,087,776
+119,030
+12% +$1.44M ﹤0.01% 2048
2013
Q4
$12.2M Buy
968,746
+449,642
+87% +$5.67M ﹤0.01% 2071
2013
Q3
$8.61M Sell
519,104
-36,165
-7% -$600K ﹤0.01% 2212
2013
Q2
$8.44M Buy
+555,269
New +$8.44M ﹤0.01% 2150